William Wesley Dunn, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3501 20th Ave, Valley, AL 36854 Phone: 334-768-2110 Fax: 334-768-2112 |
Clair Barnett Riggs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3501 20th Ave, Valley, AL 36854 Phone: 334-768-2110 Fax: 334-768-2112 |
Jeremy Powers Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3501 20th Ave, Valley, AL 36854 Phone: 334-768-2112 Fax: 334-768-2112 |
Ashton Scott Vega, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4800 48th St, Valley, AL 36854 Phone: 334-710-0275 |
Crystal Smith, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4103 20th Ave, Valley, AL 36854 Phone: 334-756-2037 Fax: 334-756-9024 |
Nancy E Martin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 89 Trammell Block, Valley, AL 36854 Phone: 334-756-2305 |
Kirsten Hood, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4500 20th Ave, Valley, AL 36854 Phone: 334-756-3219 Fax: 334-756-3811 |
Linda Lynn Sellers Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3501 20th Ave, Valley, AL 36854 Phone: 334-768-2110 Fax: 334-768-2112 |
Mr. John Hugh Hood Ii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4500 20th Ave, Valley, AL 36854 Phone: 334-756-3219 |
Mrs. Angela Barnes Moore, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4103 20th Ave, Valley, AL 36854 Phone: 334-756-2037 Fax: 334-756-9024 |
News Archive
Radiation after a mastectomy for women with advanced breast cancer saves lives, but almost half of these patients do not receive it. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. =
Even as state executives such as Texas Gov. Rick Perry and Florida Gov. Rick Scott remain firm in their opposition to the health law's Medicaid expansion, health providers such as Cleveland Clinic CEO and President Tony Cosgrove express their support for it.
A new study by researchers at the University of California, San Francisco, discusses the different aspects of long-term immune responses in a wide sample of patients, as well as how they vary in clinical severity and sequelae.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
› Verified 6 days ago